Trial Sequential Analysis in Critical Care Medicine: The Way Forward
- PMID: 36394406
- PMCID: PMC9668363
- DOI: 10.1097/CCM.0000000000005634
Trial Sequential Analysis in Critical Care Medicine: The Way Forward
Conflict of interest statement
The authors have disclosed that they do not have any potential conflicts of interest.
Comment in
-
The authors reply.Crit Care Med. 2022 Dec 1;50(12):e810-e811. doi: 10.1097/CCM.0000000000005665. Epub 2022 Nov 17. Crit Care Med. 2022. PMID: 36394407 No abstract available.
Comment on
-
Probiotics in Critical Illness: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.Crit Care Med. 2022 Aug 1;50(8):1175-1186. doi: 10.1097/CCM.0000000000005580. Epub 2022 May 25. Crit Care Med. 2022. PMID: 35608319
References
-
- Sharif S, Greer A, Skorupski C, et al. : Probiotics in critical illness: A systematic review and meta-analysis of randomized controlled trials. Crit Care Med. 2022; 50:1175–1186 - PubMed
-
- Thorlund K, Engstrøm J, Wetterslev J, et al. : User Manual for Trial Sequential Analysis (TSA). Second Edition. Copenhagen, Denmark, Copenhagen Trial Unit, 2017, pp 1–119. Available at: https://ctu.dk/tsa/. Accessed June 2, 2022
-
- Sharif S, Rochwerg B, Cook D, et al. : The Use of Probiotics and Synbiotics in Critical Illness: A Systematic Review and Meta-Analysis. 2020. Available at: https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42020157080. Accessed June 6, 2022
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
